Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) approved Rituxan Hycela™ (rituximab and hyaluronidase human) for subcutaneous (under the skin) injection, for the treatment of adults with the following blood cancers: previously untreated and relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma (DLBCL), and previously untreated and previously treated chronic lymphocytic leukaemia (CLL). (Source: World Pharma News)
from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sLYWUg
via IFTTT
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Αρχειοθήκη ιστολογίου
-
►
2023
(272)
- ► Φεβρουαρίου (141)
- ► Ιανουαρίου (131)
-
►
2022
(2066)
- ► Δεκεμβρίου (80)
- ► Σεπτεμβρίου (170)
- ► Φεβρουαρίου (190)
- ► Ιανουαρίου (203)
-
►
2021
(7399)
- ► Δεκεμβρίου (186)
- ► Σεπτεμβρίου (472)
- ► Φεβρουαρίου (851)
-
►
2020
(2517)
- ► Δεκεμβρίου (792)
- ► Σεπτεμβρίου (21)
- ► Φεβρουαρίου (28)
-
►
2019
(12076)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (4765)
- ► Ιανουαρίου (5155)
-
►
2018
(3144)
- ► Δεκεμβρίου (3144)
-
▼
2017
(66935)
- ► Δεκεμβρίου (1995)
- ► Σεπτεμβρίου (12424)
-
▼
Ιουνίου
(12984)
-
▼
Ιουν 23
(556)
- Comparison of facet joint degeneration in firefigh...
- The relationship between serum vitamin D levels an...
- Perception of and attitude toward ethical issues a...
- Mike Blevins did much more than just make great ba...
- Pure intraductal carcinoma of the parotid gland: C...
- Former executives of Chandler company face investi...
- GoFundMe to reimburse those who gave to woman's ca...
- Donors to Tualatin cancer GoFundMe to get reimburs...
- Table of Contents
- Head and neck cancer cured with THIS treatment: Sw...
- Massive Middle Cerebral Artery Infarction After Su...
- Editorial Board Page
- Antibiotic Prophylaxis in Blepharoplasty: Review o...
- Antibiotic Prophylaxis in Blepharoplasty: Review o...
- Massive Middle Cerebral Artery Infarction After Su...
- Editorial Board Page
- Table of Contents
- Alternative Distraction Osteogenesis Technique Aft...
- Alternative Distraction Osteogenesis Technique Aft...
- AAOMS Author Disclosure forms
- AAOMS Author Disclosure forms
- The Dynamic Landscape of Health Care Insurance—Imp...
- Masthead
- Masthead
- The Dynamic Landscape of Health Care Insurance—Imp...
- Endoscope-Assisted Resection of Elongated Styloid ...
- Endoscope-Assisted Resection of Elongated Styloid ...
- Improving Surgeons' Comfort With Prismatic Glasses...
- HBF Run for a Reason: Peter Symonds wants to raise...
- Parenting 101: Should my child get the HPV vaccine...
- Esami e visite, l'Uib apre lo sportello sanitario ...
- Hearing loss in enlarged vestibular aqueduct and i...
- Listing ongoing research experience in AMCAS
- Most Popular NEJM Group Feature This Week: Colorec...
- WAMC/ MD List
- Study: ACA leads to earlier breast cancer diagnoses
- The High Cost of Ageing
- FDA approves Rituxan Hycela (rituximab and hyaluro...
- Kopchicks give $10.5 million gift to MD Anderson U...
- Immunotherapy kinder than chemotherapy for patient...
- Most Popular NEJM Group Feature This Week: Colorec...
- Study: ACA leads to earlier breast cancer diagnoses
- The High Cost of Ageing
- FDA approves Rituxan Hycela (rituximab and hyaluro...
- Immunotherapy kinder than chemotherapy for patient...
- Kopchicks give $10.5 million gift to MD Anderson U...
- Should we be taking the p (value) out of statistics?
- Health-related quality of life, fear of recurrence...
- Should we be taking the p (value) out of statistics?
- Health-related quality of life, fear of recurrence...
- Amlexanox downregulates S100A6 to sensitize KMT2A/...
- NF1+/- hematopoietic cells accelerate malignant pe...
- MCAM mediates chemoresistance in small cell lung c...
- EIF1AX and NRAS mutations co-occur and cooperate i...
- Functionally null RAD51D missense mutation associa...
- Immunotherapy kinder than chemotherapy for patient...
- Rhesus Cochlear and Vestibular Functions Are Prese...
- Would Your Dog Eat You if You Died? Get the Facts.
- NCI's Center for Cancer Research (CCR) Grand Round...
- HIV Dynamics and Replication Program Conference on...
- Celebrating 21 Years of the CURE Program
- Hematopoietic Stem Cells Aging – Mechanisms, Conse...
- Law of STAT fives, root orchestrators of lymphocyt...
- Torino, Malan (FI): “M5S inadeguato a governare la...
- Verità su Rete ospedali, Primario Cascio: Assenso ...
- Would Your Dog Eat You if You Died? Get the Facts.
- Health-related quality of life, fear of recurrence...
- Why don ’t we mention “impact on intimacy” when we...
- Clinical and genetic analysis of patients with che...
- Hearing loss in enlarged vestibular aqueduct and i...
- The landmark for removal of sialoliths using siale...
- The outcomes of endoscopic management in young chi...
- Hearing loss in enlarged vestibular aqueduct and i...
- The landmark for removal of sialoliths using siale...
- The landmark for removal of sialoliths using siale...
- Hearing loss in enlarged vestibular aqueduct and i...
- The landmark for removal of sialoliths using siale...
- ASCO 2017: Most impactful studies on lung cancer
- How and when do you begin the conversation with pa...
- The optimal duration of adjuvant chemotherapy in c...
- What have we learned about duration of therapy in ...
- The outcomes of endoscopic management in young chi...
- ASCO 2017: Promising data on colorectal cancer
- The outcomes of endoscopic management in young chi...
- Gayle Jameson, MSN, ACNP-BC, AOCN - Breaking the B...
- NSCLC Patients May Benefit From Single Dose of SBRT
- Study: Stereotactic Radiation and Surgery Can Trea...
- Overview of Checkmate 032 & amp; CTONG 1104 for NSCLC
- Can pomalidomide be effective salvage therapy for ...
- Is CAR T-Cell therapy effective in treating multip...
- Is combining pembrolizumab and lenalidomide effect...
- Do CAR T-Cell therapies look promising for the tre...
- Results of GENUINE study for CLL
- What are the emerging trends in CLL management?
- The outcomes of endoscopic management in young chi...
- How to control rising drug prices without impactin...
- What interventions can alleviate financial toxicity?
- ACOG Guidance: Individualize Breast Cancer Screeni...
- Obstructive sleep apnoea in craniofacial microsomi...
- Are wealthier people more likely to receive a diag...
-
▼
Ιουν 23
(556)
Ετικέτες
Πληροφορίες
Παρασκευή 23 Ιουνίου 2017
FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Αναζήτηση αυτού του ιστολογίου
! # Ola via Alexandros G.Sfakianakis on Inoreader
-
Publication date: 1 May 2019 Source: Talanta, Volume 196 Author(s): Ruiqing Long, Te Li, Chaoying Tong, Lihui Wu, Shuyun Shi Abstract...
-
Oral Cancer Rapid Test Kit Market Rugged Expansion Foreseen by 2024 MilTech Oral cancer is one of the largest group of cancers ...
-
Related Articles SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,